
APIIC's Brian Doty on how repurposing shuttered U.S. plants with advanced manufacturing could make domestic generic drug production viable.
almost 5 years ago
Pharmaceutical Commerce - February 2022 Issue (PDF)almost 5 years ago
A Lowdown on Logisticsalmost 5 years ago
The Shifting Course in Logistics Supportalmost 5 years ago
How 3PLs Can Up Their Pharma Gamealmost 5 years ago
For Industry in Flux, is M&A Jolt in Store?almost 5 years ago
CAR-T Therapies: Three Supply Chain Considerationsalmost 5 years ago
The Risk of Doubling Down on Pharmaalmost 5 years ago
Striving for Authentic, Transparent Track and Tracealmost 5 years ago
Booster Rollout Lessons for Pharmaalmost 5 years ago
Assessing Adoption of Hybrid DtP Models





